Andrew worked many years in bio tech advancing into an engineering role at Hunter Bio, where he quickly made an impact on the microfluidic devices efficiency. Dropping the error rate of nearly 50% to around 10% for experimental accuracy, Andrew improved and tightened data dramatically and aided the bigger company goals.
He is currently making a big career change, pursuing a masters in accounting which will be complete by summer of 2026. Andrew is hardworking, driven, and intuitive. His past roles and skills developed will make it easy to transition into any company and make a direct impact on a company’s objectives.More...